Catalent has Acquired Delphi Genetics and Launches US Plasmid Manufacturing Site

Establishing global pDNA development and manufacturing capabilities to support cell and gene therapy programs from preclinical through to commercialization

Catalent Partnering with Multiple Customers on COVID-Related Vaccines and Therapies

Including Johnson & Johnson, AstraZeneca, Moderna and Humanigen

Biologics

Create better biologic treatments and speed your path to market with our range of advanced technologies and services.

Developing Biologic Drugs is Science.

Accelerating Advanced Treatments & Vaccines is Art.

Catalent has Acquired Delphi Genetics and Launches US Plasmid Manufacturing Site

Establishing global pDNA development and manufacturing capabilities to support cell and gene therapy programs from preclinical through to commercialization

Catalent Partnering with Multiple Customers on COVID-Related Vaccines and Therapies

Including Johnson & Johnson, AstraZeneca, Moderna and Humanigen

Biologics

Create better biologic treatments and speed your path to market with our range of advanced technologies and services.

Developing Biologic Drugs is Science.

Accelerating Advanced Treatments & Vaccines is Art.

How can we work together

Biologics
Development

Adeno-associated virus (AAV) close up

Gene Therapy

Cell Therapy

Technologies


CATALENT RESPONDS TO THE GLOBAL COVID-19 OUTBREAK

We are taking decisive action to minimize the impact of the COVID-19 pandemic on our employees, partners, customers, and their patients.

LEARN MORE


Cell Therapy

With our advanced technologies and expertise in both autologous and allogeneic development and manufacturing, Catalent is your full-service partner for CAR-T immunotherapies and beyond.


Gene Therapy

Our Gene Therapy team combines leading expertise in viral vector technology and scale-up with state-of-the-art CGMP facilities, including dedicated plasmid DNA manufacturing sites and our FDA approved commercial facility.


STRATEGIES TO ACHIEVE SUCCESSFUL COMMERCIAL APPROVAL & LAUNCH

Experts share how scale-up, regulatory expectations, demand forecasting and process validation all play a role in the successful launch and approval of a biologic.

Biologics Network

Our network of biologics sites provides an integrated approach to get medicines to your patients faster anywhere in the world.

SEE ALL LOCATIONS


Join Our Team

Catalent is growing in Biologics and is making significant investments in people in this area. Explore global career opportunities with our Biologics team.